SHANGHAI, March 12, 2012 /PRNewswire-Asia/ --
- Over 300 attendees working within proteins, antibodies and biotherapeutics research, upstream & downstream processing in the global interested in biopharma business in China
- Over 40 case studies, presentations and panel discussions
4 interactive streams:
- Upstream: Cell Culture
- Downstream: Protein Purification, Expression & Characterization
- Biotherapeutics
- Bioprocessing & biopharmaceutical manufacturing
- 60 prescheduled one to one business meetings & exhibitions
Contact Sky Zhong at 8621-32516030 or send email to sky.zhong@shinemediaworld.com
BioChina International 2012 will be held on June 26 and 27 in Shanghai, China. The congress is the single most focused event in Asia Pacific dedicated to key technological and scientific trends in the China Biopharmaceutical industry.
Over the 2 days, the BioChina International 2012 - Biopharma and Bioprocessing Congress will be attended by over 300 global leaders within the biopharmaceutical industry from Asia, Europe and US. The program examines the current trends and technologies in advancing upstream and downstream bioprocesses of protein and antibodies in the market. It also addresses the current developments in Protein and Antibody biotherapeutics research, cell culture and cell line development, purification & expression systems and recombinant protein therapeutics.
Confirmed & Reserved Speakers for 2012 include:
- Baoping Wang, Vice President of Novo Nordisk R&D, Novo Nordisk, China
- Dongmei Su, Chief Scientific Officer, Shenyang Sunshine Pharmaceuticals
- Zhenping Zhu, Executive Vice President, Global Biologics R&D, President & CEO, Kadmon China
- Jennifer Hu, Vice President & Head of Innovation Center China, Global Drug Discovery, Bayer HealthCare
- Zhaolong Gong, Ph.D., M.D. SVP and Chief Technology Officer, JOINN Laboratories
- Paul Coleman, COO, Bio Business Unit, Hanwha Chemical, South Korea
- Changlin Dou, Chief Technology Officer, Luye Pharma, Singapore
- Joe Zhou, CEO, Genor BioPharma, China
- Scott Liu, PhD, President and CEO, Henlius Biopharmaceuticals Inc & Shanghai Henlius Biotech Co. Ltd, China
- Lei Sun, Ph.D, Vice President, Manufacturing Business, Autekbio China
- Jian Dong, VP Manufacturing, CelgenPharm
- Bo Xu, Senior Director of Bioprocess and BioManufacturing, WuXi Apptec China
- Wei-Kuang Chi, Ph.D., Vice President & Director, cGMP Biopharm Pilot Plant Facility, Development Center for Biotechnology, Taiwan
- Jin-San Yoo, President & CEO, PharmAbcine, Inc, Republic of Korea
- Yajun Guo, MD, PhD, Director, Chinese National Engineering Research Centre for Antibody Medicine, China
- XianHong Bai, Ph.D., Chief Executive Officer, Beijing Baitai Biotech Co.
- Mahbubur Rahman, Deputy Director - Analytical Biochemistry, Analytical Process & Technology, Industrial Operations, Sanofi Pasteur
- Simon Sturge, Corporate Senior Vice President Biopharmaceuticals, Boehringer Ingelheim, Germany
- Neil Weir, Senior Vice President, UCB Pharma
- Ramkrishna (Ramu) Sadhukhan, Senior Group Leader, Abbott Bioresearch Center, USA
- Sunil Gupta, Vice President and Head, Global Biological Development, Bayer HealthCare, USA
- Huijun GAO, Deputy Director, Shanghai FDA Technology Intelligence Research Center
- Koichi Kato, Professor, Okazaki Institute for Integrative Bioscience and Institute for Molecular Science, National Institutes of Natural Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan
In addition to this, the BioChina International 2012 - Biopharma and Bioprocessing Congress will also bring together global Bioprocessing & Biopharmaceutical Manufacturing leaders within biopharmaceutical industry to explore the dynamic strategies, benchmark the latest technologies and accelerate manufacturing growth in China and Asia.
Do not miss out on presentations by over 60 industry leaders covering topic areas such as:
Upstream Production and Processing & Cell Culture
- Cell culture automation
- Optimized cell culture development
- Upstream technologies e.g. high throughput platforms
- Cell line expression technologies
- Media selection & screening methods
- Process scale up, scale down
- Optimizing Downstream technologies
Bioprocessing & biopharmaceutical Manufacturing
- Biosimilars manufacturing challenges, regulatory models and operational excellence
- Quality by Design QbD for Biopharmaceuticals
- Technology Transfer in Biopharmaceuticals
- Quality Risk Management
- Development of Biologics
- Optimal construction for biopharmaceutical facilities
- Facility design and utilization
- Disposables for Biopharmaceutical manufacturing
- Optimizing Biologic Manufacturing Operations through Single-use Technologies Application
- CMC requirements and regulation for investigational products
Protein Purification, Expression & Characterization
- Different expression systems
- Cell line cultivation and development
- Vector screening
- Recombinant protein expression
- Functional characterization
- Expression, Purification and characterization technologies
- Monoclonal Antibodies
- Antibody engineering
- Bispecific antibodies and other novel constructs
- Anti-body drug conjugates
- Formulation And Stability
About Shine Media:
Shine Media is a progressive business media, serving clients from around the world. We offer a comprehensive product mix, ranging from summits, business to business congresses, and tradeshows to made-on-demand specialty seminars. By bringing business communities together, in person, in print or online, we help decision-makers get ahead of the curve on emerging issues, make key connections, and reach out to new customers.
Source: Shine Media International Ltd.
